Teladoc (TDOC) Stock Forecast & Price Target

Teladoc Health Inc. is projected to achieve a significant increase in its Integrated Care segment revenue, with guidance suggesting a rise to $1,613.6 million for CY26, representing a year-over-year growth of $34.0 million. The BetterHelp segment is also expected to see substantial growth, with insurance revenue forecasted to increase from $13.0 million in CY25 to between $75.0 million and $90.0 million in CY26, elevating its share of overall revenue from 1.4% to 9%. Additionally, the company's Integrated Care segment is anticipated to generate an adjusted EBITDA of $251.9 million at the midpoint, reflecting a year-over-year improvement of $12.6 million, with expectations for a robust EBITDA margin in the fourth quarter.

Teladoc Health's outlook is negatively impacted by expected declines in revenue growth, particularly within the BetterHelp segment, where a reduction in membership and low-single-digit growth targets indicate significant challenges ahead. The company's shifting revenue model in the Integrated Care segment, transitioning from fee-based to visit-based arrangements, contributes to potential growth fluctuations exacerbated by decreasing health plan customer enrollment due to expiring ACA subsidies. Additionally, operational expenditure cuts aimed at maintaining profitability may compromise essential functions, leading to diminished pricing power and further undermining overall growth prospects.